Indications and Purposes
| 1 Indications And Usage Lunesta ® (Eszopiclone) Is Indicated For The Treatment Of Insomnia. In Controlled Outpatient And Sleep Laboratory Studies, Lunesta Administered At Bedtime Decreased Sleep Latency And Improved Sleep Maintenance. The Clinical Trials Performed In Support Of Efficacy Were Up To 6 Months In Duration. The Final Formal Assessments Of Sleep Latency And Maintenance Were Performed At 4 Weeks In The 6-Week Study (Adults Only), At The End Of Both 2-Week Studies (Elderly Only) And At The End Of The 6-Month Study (Adults Only). Lunesta Is Indicated For The Treatment Of Insomnia. Lunesta Has Been Shown To Decrease Sleep Latency And Improve Sleep Maintenance ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Eszopiclone |
|
ZINC19632834 |